J&J Lifts Full-Year Sales Outlook, Fueled by Pharma, Med-Device Gains

Core Insights - Johnson & Johnson raised its full-year sales outlook due to gains in both its prescription-drug and medical-device businesses in the latest quarter [1] Company Performance - The company reported an increase in sales across its prescription-drug segment, contributing positively to the overall financial outlook [1] - Gains in the medical-device business also played a significant role in enhancing the company's sales projections for the year [1]